CTDHUnknown
Cyclo Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Cyclo Therapeutics, Inc. (CTDH), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are CTDH insiders buying or selling?
Cyclo Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since December 2018, Trabud has recorded 50 Form 4 filings for CTDH: 44 buys ($907.2K) and 6 sells ($503.6K).
Source: SEC EDGAR Form 4
Key Statistics (December 2018 – Nov 25, 2020)
Total Form 4 filings
50
SEC EDGAR
Insider filers
11
Insider buys (44)
$907.2K
Insider sells (6)
$503.6K
Insider sentiment
Net buyingNet insider flow of $403.6K in net buying since December 2018.
Recent CTDH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 25, 2020 | Joshua M Fine | Chief Financial Officer | Purchase | 25.0K | $0.08 | $1.9K | SEC ↗ |
| Oct 1, 2020 | Steven Boyd | 10% Owner | Sale | 10.5K | $0.13 | $1.4K | SEC ↗ |
| Sep 28, 2020 | Steven Boyd | 10% Owner | Sale | 43.2K | $0.13 | $5.6K | SEC ↗ |
| Sep 23, 2020 | Steven Boyd | 10% Owner | Sale | 167.0K | $0.15 | $24.6K | SEC ↗ |
| Sep 17, 2020 | Steven Boyd | 10% Owner | Sale | 337.1K | $0.16 | $55.2K | SEC ↗ |
| Sep 11, 2020 | Steven Boyd | 10% Owner | Sale | 1.0M | $0.18 | $176.0K | SEC ↗ |
| Sep 8, 2020 | Steven Boyd | 10% Owner | Sale | 1.5M | $0.16 | $240.8K | SEC ↗ |
| Sep 2, 2020 | NOVIT, L.P. | 10% Owner | Purchase | 10.0M | $0.00 | $0 | SEC ↗ |
| Aug 31, 2020 | Steven Boyd | 10% Owner | Purchase | 165.3K | $0.11 | $18.7K | SEC ↗ |
| Aug 31, 2020 | Sieger Markus | Director | Purchase | 750.0K | $0.00 | $0 | SEC ↗ |
| Aug 31, 2020 | William S Shanahan | Director | Purchase | 700.0K | $0.00 | $0 | SEC ↗ |
| Aug 28, 2020 | Francis Patrick Ostronic | Director | Purchase | 500.0K | $0.00 | $0 | SEC ↗ |
| Aug 28, 2020 | FINE N SCOTT | Chief Executive Officer | Purchase | 500.0K | $0.00 | $0 | SEC ↗ |
| Apr 27, 2020 | FINE N SCOTT | Chief Executive Officer | Purchase | 730.0K | $0.10 | $73.0K | SEC ↗ |
| Apr 27, 2020 | Randall M. Toig | Director | Purchase | 1.0M | $0.10 | $100.0K | SEC ↗ |
| Apr 27, 2020 | Sieger Markus | Director | Purchase | 500.0K | $0.10 | $50.0K | SEC ↗ |
| Apr 27, 2020 | NOVIT, L.P. | 10% Owner | Purchase | 2.0M | $0.10 | $200.0K | SEC ↗ |
| Apr 27, 2020 | Francis Patrick Ostronic | Director | Purchase | 1.0M | $0.10 | $100.0K | SEC ↗ |
| Apr 27, 2020 | William S Shanahan | Director | Purchase | 1.0M | $0.10 | $100.0K | SEC ↗ |
| Sep 19, 2019 | FINE N SCOTT | Chief Executive Officer | Purchase | 10.0K | $0.17 | $1.8K | SEC ↗ |
| Sep 18, 2019 | William S Shanahan | Director | Purchase | 147.2K | $0.19 | $28.0K | SEC ↗ |
| Sep 18, 2019 | Francis Patrick Ostronic | Director | Purchase | 100.0K | $0.19 | $19.0K | SEC ↗ |
| Sep 13, 2019 | William S Shanahan | Director | Purchase | 15.0K | $0.19 | $2.9K | SEC ↗ |
| Sep 13, 2019 | Francis Patrick Ostronic | Director | Purchase | 1.0K | $0.18 | $180 | SEC ↗ |
| Sep 12, 2019 | Randall M. Toig | Director | Purchase | 100.0K | $0.20 | $20.0K | SEC ↗ |
Showing the 25 most recent of 50 Form 4 filings for Cyclo Therapeutics, Inc..
Most active CTDH insiders
- Francis Patrick Ostronic9 filings
- William S Shanahan8 filings
- Steven Boyd7 filings
- FINE N SCOTT6 filings
- Sieger Markus5 filings
Ask anything about CTDH insider activity
Use Trabud's AI agent to query Cyclo Therapeutics, Inc.'s Form 4 history in plain English — "Show me CTDH CEO purchases this year" or compare it against any other ticker.
Open the AI agentCTDH insider trading FAQ
Are Cyclo Therapeutics, Inc. insiders buying or selling?
Cyclo Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since December 2018, Trabud has recorded 50 Form 4 filings for CTDH: 44 buys ($907.2K) and 6 sells ($503.6K). Over the full record that is net buying of $403.6K.
How many insiders trade CTDH stock?
11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Cyclo Therapeutics, Inc.. The most recent filing was accepted on Nov 25, 2020.
Where does Trabud get CTDH insider trading data?
All CTDH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.